CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 1,842,038
- Share change
- -201,774
- Total reported value
- $4,363,682
- Price per share
- $2.37
- Number of holders
- 20
- Value change
- -$463,905
- Number of buys
- 4
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
3.5%
|
528,163
|
$676,049 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.5%
|
374,251
|
$479,041 | — | 30 Sep 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
286,655
|
$366,918 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
284,005
|
$363,526 | — | 30 Sep 2024 | |
| Martin E. Cearnal |
3/4/5
|
Sr VP/Chief Commercial Officer, Director |
—
class O/S missing
|
163,473
|
$277,904 | — | 17 Mar 2022 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.2%
|
188,164
|
$239,000 | — | 30 Sep 2024 | |
| Leo Pavliv |
3/4/5
|
SVP and Chief Development Off. |
—
class O/S missing
|
129,618
|
$220,351 | — | 31 May 2022 | |
| Joey A. Jacobs |
3/4/5
|
Director |
—
class O/S missing
|
98,415
|
$167,306 | — | 14 Jan 2023 | |
| BlackRock, Inc. |
13F
|
Company |
0.73%
|
110,068
|
$140,887 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.5%
|
75,268
|
$96,343 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
74,305
|
$95,126 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
33,700
|
$43,136 | — | 30 Sep 2024 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.14%
|
21,275
|
$27,232 | — | 30 Sep 2024 | |
| Jonathan Griggs |
3/4/5
|
Director |
—
class O/S missing
|
14,803
|
$25,165 | — | 17 Mar 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.13%
|
19,378
|
$24,804 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.11%
|
16,322
|
$20,892 | — | 30 Sep 2024 | |
| Michael Bonner |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
11,720
|
$19,924 | — | 17 Mar 2021 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.07%
|
10,000
|
$12,800 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
9,671
|
$12,379 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.04%
|
6,166
|
$7,892 | — | 30 Sep 2024 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$3,907 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
2,660
|
$3,405 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
250
|
$320 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
219
|
$280 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
139
|
$178 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
100
|
$128 | — | 30 Sep 2024 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2024 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q4 2024
As of 31 Dec 2024,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,842,038 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
22
Q4 2024 holders
20
Holder diff
-2
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.